Work

Comprehensive metabolomic profiling of plasma from patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors (ICI) or platinum-based chemotherapy (PBC).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.565

Authors: Talal El Zarif, Elio Adib, Clary Clish, Sachet A. Shukla, Dory Freeman, Jonathan Thomas, Praful Ravi, Martha Tuff, Bradley Alexander McGregor, Charlene Mantia, Arvind Ravi, Guru P. Sonpavde

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Broad Institute, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Metabolomics and Mass Spectrometry Studies

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4213114913

Cites:

Cited by: 1

Related to: 10